EU regulator backs revoking Amgen's right to sell rare-disease drug - Reuters
EU regulator backs revoking Amgen's right to sell rare-disease drug Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMi3AFBVV95cUxPQW1xek5kR0ljZzlCOUtEVnNfSWhSb2hVSVIxcTVGaWpoVllvaFF6VVhlNlRFNWtLWFFTc3lmcXpqZXZDOFk5UXFOZTdrTEdXS2diS0w0T21XWC1ZeVd1SUx2dXhTRU5HR1JGQUY3VTdKZlM5R2lzRFVDUl9KTVhmclRFSTV3aVU4MHBTd1BLZFRlM3NneUJkQTZXXzFmdm5rZFpfZmhUUkxpTWNiLVhOSVg5SkVqZ1RQSmNZSWY5YTI2TW5sX3NxOFk1bTU5TlpjZXhrUFI2TzRWZ2hE?oc=5" target="_blank">EU regulator backs revoking Amgen's right to sell rare-disease drug</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
US FDA approves Regeneron's rare bone disorder drug - Reuters
US FDA approves Regeneron's rare bone disorder drug Reuters
August 19, 2026 at 06:53 PMNovartis defeats UK court bid to invalidate blockbuster drug Entresto patent - Reuters
Novartis defeats UK court bid to invalidate blockbuster drug Entresto patent Reuters
August 13, 2026 at 09:31 PMLawsuit against Bristol Myers over delayed cancer drug is revived - Reuters
Lawsuit against Bristol Myers over delayed cancer drug is revived Reuters
August 13, 2026 at 06:00 PMUS FDA approves Bristol Myers' blood cancer treatment - Reuters
US FDA approves Bristol Myers' blood cancer treatment Reuters
August 13, 2026 at 09:33 PMCapricor shares skyrocket as FDA agrees to review new Duchenne drug data - Reuters
Capricor shares skyrocket as FDA agrees to review new Duchenne drug data Reuters
August 14, 2026 at 10:41 AMHumana agrees not to reference Teva's Israel ties at US drug trial - Reuters
Humana agrees not to reference Teva's Israel ties at US drug trial Reuters
August 13, 2026 at 03:33 PM